Comparing the cost, glycaemic control and medication adherence of utilizing patients’ own medicines (POMs) versus usual dispensing among diabetic patients in an outpatient setting

Abstract

Background

Millions worth of unused drugs particularly those indicated for chronic diseases such as diabetes were returned and disposed leading to substantial wastage. Use of patients’ own medications (POMs) in the inpatient setting has reduced wastage and saved cost. The impact of utilizing POMs in the outpatient setting has hitherto not been determined.

Purpose

This study aims to compare the cost, medication adherence and glycaemic control of utilizing POMs versus usual dispensing.

Methods

Prospective randomized controlled study was conducted among diabetic patients that required monthly medication refill in the Outpatient Pharmacy in 2017. Patients who consented were equally divided into POMs and control groups. Both groups brought excess medications from home at week-0 and week-12. Patients in the POMs group brought excess medications monthly and sufficient amount of drugs were added until the next refill date. Drugs were dispensed as usual in the control group. Total cost consisting of the cost of drugs, staff and building was calculated. Glycosylated haemoglobin (HbA1c) was measured at baseline and week-12. Adherence was measured based on pill counting.

Results

Thirty patients aged 56.77 ± 14.67 years with 13.37 ± 7.36 years of diabetes participated. Baseline characteristics were similar between the groups. POMs minimized the total cost by 38.96% which translated to a cost saving of USD 42.76 ± 6.98, significantly different versus USD 0.02 ± 0.52 in the control group, p = 0.025. Mean HbA1c reduced significantly (−0.79%, p = 0.016) in the POMs group but not significant in the control group (−0.11%, p = 0.740). Medication adherence improved significantly in both groups at week-12 (p < 0.010). Nevertheless, patients in the POMs group were more adherent, 87.20% vs. 66.32%, p = 0.034.

Conclusion

Utilizing POMs resulted in cost saving, improved adherence and better glycaemic control. Use of POMs should be practiced in the outpatient pharmacy to reduce wastage and cost.

Graphical abstract

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. 1.

    Trueman P, Lowson K, Blighe A. Evaluation of the scale, causes and costs of waste medicine. Final Report. York Health Economics and University of London. 2010. https://discovery.ucl.ac.uk/id/eprint/1350234. Accessed 20 July 2020.

  2. 2.

    Law AV, Skahrakar P, Zargarzadeh A, Tai BW, Hess K, Hata M, et al. Taking stock of medication wastage: unused medicines in US household. Res Soc Adm Pharm. 2015;11:571–8.

    Article  Google Scholar 

  3. 3.

    Organisation for Economic Co-operation and Development. OECD Health Data: Social protection. 2014. https://doi.org/10.1787/data-00544-en. Accessed on 20 July 2020.

  4. 4.

    Reinhardt UE, Cheng T-M. The world health report 2000 - health systems: improving performance. Bull World Health Organ. 2000;78(8):1064.

    PubMed Central  Google Scholar 

  5. 5.

    Feisul IM, Azmi S, Mohd Rizal AM, Zanariah H, Nik Mahir NJ, Fatanah I, et al. What are the direct medical costs of managing Type 2 Diabetes Mellitus in Malaysia? Med J Malaysia. 2017;72:271–7.

    CAS  PubMed  Google Scholar 

  6. 6.

    Institute for Public Health. National Health and Morbidity Survey 2015 (NHMS 2015). Vol II: Non-communicable diseases, risk factors & other health problems. Kuala Lumpur: Ministry of Health; 2015.

    Google Scholar 

  7. 7.

    Lau B. RM 2 million worth of expired drugs have been disposed by MOH. In: MIMS Today. MIMS Pte. Ltd. https://today.mims.com/rm2-million-worth-of-expired-drugs-have-been-disposed-by-moh. Accessed 20 July 2020.

  8. 8.

    Aitken M, Valkova S. Avoidable costs in US healthcare: the $200 billion opportunity from using medicines more responsibly. Report. Connecticut: IMS Institute for Healthcare Informatics; 2013.

  9. 9.

    van Herpen-Meeuwissen LJM, van den Bemt BJF, Derijks HJ, van den Bemt PMLA, de Vries F, Maat B, et al. Economic impact of patients’ own medication use during hospitalization: a multicentre pre-post implementation study. Int J Clin Pharm. 2019;41:1658–65.

    Article  Google Scholar 

  10. 10.

    Newman C. How to reduce medicines waste. Clin Pharm. 2011;3:26.

    Google Scholar 

  11. 11.

    Wong YC. Cost impact of using patients own multidose medications in hospital. Can J Hosp Pharm. 2014;67:9–16.

    PubMed  PubMed Central  Google Scholar 

  12. 12.

    Asare AF, Safda A, Tomlin S, Hayes P. Cost savings from using patients own drugs in a paediatric hospital. Clin Pharm. 2009;1:489–90.

    Google Scholar 

  13. 13.

    Lim PC, Lim K, Embee ZC, Hassali MA, Thigarajan A, Khan TH. Study investigating the impact of pharmacists involvement on the outcomes of diabetes medication adherence program Malaysia. Pak J Pharm Sci. 2016;29:595–601.

    PubMed  Google Scholar 

  14. 14.

    Muller J. Average exchange rate of Malaysian ringgit to U.S. dollars 2014–2018. Statista GmBH. 2020. https://www.statista.com/statistics/863826/malaysia-exchange-rate-between-ringgit-and-usdollar. Accessed 1 Nov 2020.

  15. 15.

    Grymonpre RE, Didur CD, Montgomery PR, Sitar DS. Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly. Ann Pharmacother. 1998;32:749–54.

    CAS  Article  Google Scholar 

  16. 16.

    Farsaei S, Sabzghabaee AM, Zargarzadeh AH, Amini M. Adherence to glyburide and metformin and associated factors in type 2 diabetes in Isfahan, Iran. Iran J Pharm Res. 2011;10:933–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. 17.

    Baisley K, Baeten JM, Hughes JP, Donnell DJ, Wang J, Hayes R, et al. Summary measures of adherence using pill counts in two HIV prevention trials: the need for standardisation in reporting. AIDS Behav. 2013;17:3108–19.

    Article  Google Scholar 

  18. 18.

    Hassali MA, Supian A, Ibrahim MI, Al-Qazaz HK, Al-Haddad M, Saleem F, et al. The characteristics of drug wastage at the Hospital Tuanku Jaafar Seremban, Malaysia: a descriptive study. J Clin Diagn Res. 2012;6:787–90.

    Google Scholar 

  19. 19.

    Aziz AMA, Ibrahim MIM. Medication noncompliance - a thriving problem. Med J Malaysia. 1999;54:192–9.

    CAS  PubMed  Google Scholar 

  20. 20.

    Doyle S. Canada lags behind United States in drug return, reuse and recycling programs. CMAJ. 2010;182:197–8.

    Article  Google Scholar 

  21. 21.

    Steering Group on Improving Use of Medicines. Improving the use of medicines for better outcomes and reduced waste: an action plan. Department of Health and Social Care. 2012. https://www.gov.uk/government/publications/action-plan-for-improving-the-use-of-medicines-and-reducing-waste. Accessed 20 July 2020.

  22. 22.

    Toh MR, Chew L. Turning waste medicines to cost savings: a pilot study on the feasibility of medication recycling as a solution to drug wastage. Palliat Med. 2017;31:35–41.

    Article  Google Scholar 

  23. 23.

    Clinical Practice Guidelines Task Force. Clinical practice guidelines: Management of Type 2 Diabetes Mellitus. 5th ed. Kuala Lumpur: Ministry of Health; 2017.

    Google Scholar 

  24. 24.

    Sharifa Ezat WP, Azimatun NA, Amrizal MN, Rohaizan J, Saperi BS. Economic burden of diabetic care in government health facilities in Selangor. Community Dent Health. 2009;15:17–26.

    Google Scholar 

  25. 25.

    Wang W, Fu CW, Pan CY, Chen W, Zhan S, Luan R, et al. How do Type 2 Diabetes Mellitus-related chronic complications impact direct medical cost in four major cities of urban China? Value Health. 2009;12:923–9.

    Article  Google Scholar 

  26. 26.

    van Eikenhorst L, Taxis K, van Dijk L, de Gier H. Pharmacist-led self-management interventions to improve diabetes outcomes. A systematic literature review and meta-analysis. Front Pharmacol. 2017;8:891. https://doi.org/10.3389/fphar.2017.00891.

    Article  PubMed  PubMed Central  Google Scholar 

  27. 27.

    Aziz H, Hatah E, Bakry MM, Islahudin F. How payment scheme affects patients’ adherence to medications? A systematic review. Patient Prefer Adherence. 2016;10:837–50.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

There is no funding involved in this study. The authors thank the Director General of Health Malaysia for the permission to publish this paper.

Author information

Affiliations

Authors

Contributions

PCL and SLL designed and planned the study. PCL, YYC, SJT, TYW, DD, and TKC conducted the study and collected tha data. PCL analysed the data. PCL and CYL wrote the report.

Corresponding author

Correspondence to Chong Yew Lee.

Ethics declarations

Ethical approval

Ethical approval was obtained from the Medical Research Ethics Committee, Ministry of Health, Malaysia (NMRR-17-538-35,079).

Conflict of interest

The authors declare no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Lim, P.C., Chung, Y.Y., Tan, S.J. et al. Comparing the cost, glycaemic control and medication adherence of utilizing patients’ own medicines (POMs) versus usual dispensing among diabetic patients in an outpatient setting. DARU J Pharm Sci (2021). https://doi.org/10.1007/s40199-021-00389-6

Download citation

Keywords

  • Cost
  • Glycaemic control
  • Patients’ own medicines
  • Medication adherence
  • Outpatient